These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11299769)

  • 1. Mechanism of differential sensitivity to cisplatin in nasopharyngeal carcinoma cells.
    Wang X; Masters JR; Wong YC; Lo AK; Tsao SW
    Anticancer Res; 2001; 21(1A):403-8. PubMed ID: 11299769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
    Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
    Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
    Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
    Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
    Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
    Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
    Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced sensitivity of ovarian cell line to cisplatin induced by mifepristone and its mechanism].
    Qin TN; Wang LL
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Apr; 22(4):344-6. PubMed ID: 12390742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells.
    Cho HJ; Kim JK; Kim KD; Yoon HK; Cho MY; Park YP; Jeon JH; Lee ES; Byun SS; Lim HM; Song EY; Lim JS; Yoon DY; Lee HG; Choe YK
    Cancer Lett; 2006 Jun; 237(1):56-66. PubMed ID: 16009487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O; Arce F; Gätjens-Boniche O; Díaz C
    Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells.
    Li HL; Ye KH; Zhang HW; Luo YR; Ren XD; Xiong AH; Situ R
    Cell Res; 2001 Dec; 11(4):311-5. PubMed ID: 11787776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of chemoresistance to cisplatin in ovarian cancer cell lines.
    Murata T; Haisa M; Uetsuka H; Nobuhisa T; Ookawa T; Tabuchi Y; Shirakawa Y; Yamatsuji T; Matsuoka J; Nishiyama M; Tanaka N; Naomoto Y
    Int J Mol Med; 2004 Jun; 13(6):865-8. PubMed ID: 15138626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
    Peng X; Li W; Tan G
    Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Methoxyestradiol induces cell cycle arrest and apoptosis of nasopharyngeal carcinoma cells.
    Zhou NN; Zhu XF; Zhou JM; Li MZ; Zhang XS; Huang P; Jiang WQ
    Acta Pharmacol Sin; 2004 Nov; 25(11):1515-20. PubMed ID: 15525476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells.
    Villedieu M; Louis MH; Dutoit S; Brotin E; Lincet H; Duigou F; Staedel C; Gauduchon P; Poulain L
    Gynecol Oncol; 2007 Apr; 105(1):31-44. PubMed ID: 17275076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
    Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment of endometrial carcinoma cell lines with butyrate results in upregulation of Bax and correlates with potentiation of radiation induced cell kill.
    Adhikari D; Feroz F; Liefshitz A; Barakat RR; Bertino JR; Banerjee D
    In Vivo; 2000; 14(5):603-9. PubMed ID: 11125544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual apoptotic effect of Xrel3 c-Rel/NF-kappaB homolog in human cervical cancer cells.
    Shehata M; Shehata M; Shehata F; Pater A
    Cell Biol Int; 2004; 28(12):895-904. PubMed ID: 15566959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
    Kim R; Tanabe K; Uchida Y; Emi M; Toge T
    Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma.
    Beale PJ; Rogers P; Boxall F; Sharp SY; Kelland LR
    Br J Cancer; 2000 Jan; 82(2):436-40. PubMed ID: 10646901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.